Reddit Posts
InterCure Stock Eyes Breakout as Trump Signals Cannabis Rescheduling, Expanding Flowery Partnership $INCR
InterCure Stock Eyes Breakout as New Attention as Trump Signals Cannabis Rescheduling, Expanding Flowery Partnership $INCR
Israeli Cannabis Leader InterCure Snatches Up Premium Tech Company as Trump Signals Rescheduling $INCR
$INCR - InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands (NASDAQ: INCR)
Mentions
I've been thinking of adding more to my INCR position but will only do so below my current avg (my avg is below 5). I got carried away with my glass trade and ended up buying way too early in 8.20s..now looking for a strategy to exit with minimal damage..let's see how it goes... Yup I think the etf expiry has an oversized influence on the sector and now that we are over it (atleast until Oct monthly Opex), we should see some movement in either direction.. Been tracking RYM as well as surprisingly it's been steady and above 20. I am starting to think it's the new floor esp after their branding deal announcement from April last year..very tempted to get back in but holding back for now. It will eventually fly when they announce the hemp drinks extension/regulation (likely through an omnibus bill to advert dec shutdown imo)... Glta
My recent buys in glass are for a quick bounce back trade. I don't fancy holdin it longterm (except for my og position with mid 4 avg).. Agree on the INCR as they are now mostly derisked with the recent infusion of cash from the Israeli govt. Just waiting for their next move. Glta
I gave GLAS a look. Like the rotation setup. But I don't know the company well enough, largely because my spidey sense has always said stay away. I'll likely regret passing on the trade, ha. I did buy a starter position in INCR this morning, at $5.33. Just a nibble for now. You've followed/traded Intercure, right?
INCR completed it's r/s and Geo posted an excerpt of their NR yesterday. Their news release also announced receipt of a total of 77 million usd in compensation (34 previously received in jun and 43 now). They also have a some warrants based credit financing lined from their recent acquisition. So based on their current market cap (66mn fully diluted / 44mn free float), it looks they have over two third's of their value in just cash. I hadn't noticed this yesterday and cashed out at open on my trade from last week ...but on second look it does look like they are in good position esp given their long term interest in entering into US medical. Glta
INCR is in the trash pile getting incinerated. Thanks for sharing.
Definitely following it to see if there's a split overreaction. I was buying back in March/April though, so I'm only buying more right now if there's a pretty significant reaction to the split. I mentioned Lexaria a few weeks ago. Randomly they announced their reverse split date a few hours later. They proceeded to drop well below their all time low purely because of the split. All the way from like $8 into the low $4s. Just a few weeks later they are trading above $11. I again made good money taking advantage of reverse split nonsense. However i will need to see more of a reaction from INCR before doing the same here. Since they were trading a decent bit below the current level fairly recently.
Bought some INCR for a quick swing trade. Let's see how that plays out. Cheers
I had added a lil bit to my INCR position the week before. Contemplating now if I should take some profits before r/s vote scheduled for next week.
I am still intrigued by INCR's quick rise this past week though.
Exited some of my INCR position for decent 30% gain..take them profits whenever you can..glta
INCR has been moving up on decent volumes this week.
I also have INCR on my list and it's now slowly starting to move.
>On the day of the S3 Executive Order my largest position by far was in [CWEB Has this now changedged to INCR now, cos I moved a bit of my CWEB gains into it. Glta
Nearly 15x of normal daily avg ( 3 months) , so that's definitely something. >InterCure is already connected to OGI and CWEB, so it would fill out BAT's global footprint nicely. I was aware of their (INCR) supply agreement with OGI, but I didn't think it was anything strategic.
I thought that Tilray Brands pulled out of Israel. Does anyone know? The last I heard about Tilray exports to Israel was this โ-> **Israel โ Prior to the start of the COVID pandemic, Tilray Brands entered into a strategic agreement with Canndoc Ltd., a wholly-owned subsidiary of InterCure Ltd. (TASE: INCR), to export medical cannabis to Israel.** Then Irwin Simon visited Israel about 11 months ago to meet with Israel leaders. Israelโs total population is just shy of 10 million. Any factual information would be helpful. Thank you.
**INCR** U.S.: Nasdaq this morning $2.19 +$0.06 outstanding shares 45.57M, public float 25.56M lightly trade; avg daily vol 33.9K
https://static.nhtsa.gov/odi/inv/2022/INCR-EA22002-14496.pdf There was actually one death directly attributable to FSD beta in row 4 of the chart. In any case there have been multiple videos released in the last year of Tesla vehicles using FSD on closed course test tracks completely annihilating cardboard cutouts of children or other obstacles in the road without braking. A few years ago you could have made the argument that they didn't detect them as humans because they were just cutouts, but Tesla FSD works (I use that word liberally) completely off of camera vision now and wouldn't have any technical reason not to identify an image of a child as an actual person to avoid. There is just zero way that they get approval for unsupervised FSD at this time without massive improvements to this technology. Personally I would guess that with the current hardware unsupervised FSD is just not possible, unless they put the ultrasonic sensors or some other sensors to complement vision back in. Operating FSD completely based on cameras was a cost cutting measure pushed for by Elon Musk and it was a real bonehead move because it's just not technically feasible for a variety of reasons. Get back to me when Tesla enables all the features they had even a few years ago, as currently Smart Summon and Autopark are still disabled after a couple of years since removing the ultrasonic sensors. If the vehicle can't even navigate a parking lot or park between a couple of painted lines on its own, how is it going to handle real world driving scenarios?
Im in INCR right now, they are about to make a move amd push into germant after april 1st ๐๐ผ๐๐ผ
>I really see INCR as a sleeping giant now I'm curious.
I add to my positions in an attempt to CAD. Itโs either TCNNF, GTBIF, or TLRY. However, I really see INCR as a sleeping giant ๐ค
Iโve been saying that INCR is a prime target for awhile now. Extremely undervalued, and historically profitable with a good cash to debt ratio. I would like more details around their facility the Israeli forces had been staging troops at
Also INCR, FLGC, XXII off the top of my head
The most undervalued that is also high quality, yes. My weedstock portfolio is roughly: 65% Trulieve, 25% GTI, 10% Verano. Tiny position in INCR as well. So Iโm a little biased haha
If youโre looking for safest, itโs GTI (low debt, profitable, plenty of cash). The best are generally considered the tier 1โs, although I donโt believe them all to be on the same playing field. Personally, GTI, Trulieve & Verano stand out to me (and those are my only positions along with INCR)
From what gather the best values in Canada might be: OGI, HITI, AVTBF, INCR and possibly Decibel seem look diamonds in the rough.
Each new day this week an LP makes an announcement about dillution. This board is to keep people up to speed. Hardly anybody noticed the TLRY dilution proposal (increasing authorized shares in next company meeting) because nobody has time to read the filings. I've got no shorts on since the HHS news, only some leaps and calls for Oct 20th. CGC, INCR, SNDL, alittle MSOS.
Loaded up on InterCure INCR this morning. Feel like $1.56 entry with a stop at $1.49 is a nice risk/reward swing
InterCure just had a nice little spike up, let's see if it holds. My dream scenario (for my wallet) is that BAT is going to roll up OGI/INCR/TLRY, and maybe throw in CRON's Israel assets as well. BAT cares a lot more about international anyway, and that'd give CRON more cash to make their US play. Would also make sense why OGI didn't seek another extension before reverse splitting, and why they're doing financials on BAT's ex-div date. Not to mention we have a bit more support for Simon pursuing Hain Celestial connections, given the recent MedMen appointment.
Yea the last leg down on IIPR sucked. Hard to find what your asking for ;)! Maybe scotts miricle grow or some ancillary business?? INCR done okay, but they had a reverse split so im not keen on it
Just find a laggard unless you wanna buy after its risen 5-10%. I grabbed 500 shares of INCR in pre-market. Bought withen the prior dayโs range, looks like a consollidation period and if today goes as planned, it breaks out. Also loading another 50k shares of STMH for their upcoming reverse merger. Stem holdings, and its not known about so today should allow some liquidity grab.
Don't forget OGI when mentioning Germany. They already do a lot of international sales, and besides investing in OGI and CWEB, BAT was the lead investor in the German company Sanity Group. [https://sanitygroup.com/en/our-purpose/](https://sanitygroup.com/en/our-purpose/) Beena Goldenberg (OGI) said on the Seeking Alpha podcast a couple months ago that there have been discussions with German companies. I would not be surprised to see an OGI supply agreement with "Sanity Medical" at some point. Might involve Tilray too, as there could also be a perfect opportunity for BAT's other investment (CWEB) to supply CBD through "Sanity Care". Tilray is manufacturing CWEB product in Canada. OGI and CWEB already both have international deals with a single company (InterCure in Israel). Tilray also used to be heavily involved w/ InterCure (supply deal / Auerbach took INCR public). So I think OGI/CWEB/TLRY all getting back together for a similar German connection with Sanity Group would make a ton of sense.
I think it's hard enough to figure out US politics from what they say publicly, let alone in Germany. I'm trying to just focus on following the money. Casa Verde Capital has still been pretty active over the past year or so, despite the market being garbage. Two German investments in Sanity Group (BAT was lead investor) and Cansativa (TLRY just announced deal). OGI also very recently invested in a Casa Verde company (Greentank). TLRY/OGI/CWEB/INCR/BAT/Casa Verde seem to be pretty interconnected, and all seem to still be optimistic about EU stuff. I am more confident in those organizations' interpretation of EU progress vs my own, so I am more hopeful for a positive German result than I otherwise would be. I generally expect to be let down by government announcements.
Iโve bought a few shares of the Israeli company Intercure INCR. It is net positive at .23 a share and appears to have a good foothold in Europe.
I keep an eye on INCR. Been moving into and out of the position (only a few hundred shares, trying to get a lucky entry). Missed the move today from earnings though! That would made my monies back from 2023 on the name. Darn. Congrats to anyone who bought under $2.00 USD. Their share history/reverse split scares me on the chart. So got shaken out and scared when we dropped below $2.00 a week or two ago.
Cannabis Names that are up and coming: HITI INCR MRMD GTBIF SHWZ
Yep. Saw their agreement for a deal to supply InterCure INCR with high grade cannabis. Could really be a big deal if the contract succeeds and they extend it fully. Snagged some INCR last couple if weeks as well. OGI looks good investment wise but gives me flash backs.
Intercure $INCR quietly put up some strong numbers (again) a few days ago: https://www.intercure.co/news-releases/news-release-details/intercure-announces-record-breaking-third-quarter-financial
Those that are already in the German med market like IMCC, TLRY, SBX, INCR, ACB, CGC And then those who have a eu-gmp license like OGI, VFF, LABS, CURA, VLNS Probably forgot some that are listed on a exchange, than there are a few that are private like Materia for example.
INCR is essentially an Israeli pure play (with minor expansion into Europe) and posting net income positive with explosive growth. IMCC is interesting, but I would argue that INCRโs balance sheet is much stronger ($96m cash vs $6m)
https://www.intercure.co/news-releases/news-release-details/intercure-reports-record-breaking-second-quarter-financial Not sure why Intercure ($INCR) gets no love on hereโฆ
INCR is a much better play on Israel - and theyโre profitable and not completely inept
Intercure (INCR) is a very under the radar company putting up strong numbers in Israel. Definitely a prime takeover target for all these companies trying to become โglobal leadersโ, especially if Israel were to go full adult use
Just bought INCR long. 42 million shares outstanding. Crazy revenue growth. Market cap way low.
We will see, I wouldn't be unhappy if the MSOs could profit from a legalization in Germany. Also there are already some European companies in the market like InterCure (Nasdaq: INCR) with its subsidiary Canndoc which should profit even more. And there is a massive amount of CBD companies (mostly privat but not all) which will convert on day one.